

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyketide metabolic process (GO:0030638) | 8.05804721 |
| 2 | doxorubicin metabolic process (GO:0044598) | 8.05804721 |
| 3 | daunorubicin metabolic process (GO:0044597) | 8.05804721 |
| 4 | protein localization to kinetochore (GO:0034501) | 6.26444437 |
| 5 | maintenance of protein location in nucleus (GO:0051457) | 5.87349082 |
| 6 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 5.63185516 |
| 7 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 5.55329101 |
| 8 | heterochromatin organization (GO:0070828) | 5.55133048 |
| 9 | histone H4-K8 acetylation (GO:0043982) | 5.54204204 |
| 10 | histone H4-K5 acetylation (GO:0043981) | 5.54204204 |
| 11 | regulation of response to osmotic stress (GO:0047484) | 5.50701773 |
| 12 | histone H4-K12 acetylation (GO:0043983) | 5.44826926 |
| 13 | nuclear pore complex assembly (GO:0051292) | 5.44722569 |
| 14 | regulation of telomere maintenance via telomerase (GO:0032210) | 5.40813206 |
| 15 | mitotic sister chromatid segregation (GO:0000070) | 5.29205297 |
| 16 | negative regulation of epidermis development (GO:0045683) | 5.22541179 |
| 17 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 5.19196080 |
| 18 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.18313395 |
| 19 | somite rostral/caudal axis specification (GO:0032525) | 5.17245979 |
| 20 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 5.06344611 |
| 21 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 5.04119019 |
| 22 | Golgi transport vesicle coating (GO:0048200) | 4.98849357 |
| 23 | COPI coating of Golgi vesicle (GO:0048205) | 4.98849357 |
| 24 | negative regulation of telomerase activity (GO:0051974) | 4.98048518 |
| 25 | protein localization to chromosome, centromeric region (GO:0071459) | 4.90848069 |
| 26 | nuclear pore organization (GO:0006999) | 4.88568472 |
| 27 | pre-miRNA processing (GO:0031054) | 4.79478213 |
| 28 | DNA replication-dependent nucleosome organization (GO:0034723) | 4.77566427 |
| 29 | DNA replication-dependent nucleosome assembly (GO:0006335) | 4.77566427 |
| 30 | muscle organ morphogenesis (GO:0048644) | 4.73457725 |
| 31 | chromatin assembly (GO:0031497) | 4.72200649 |
| 32 | sister chromatid segregation (GO:0000819) | 4.65576262 |
| 33 | rRNA transcription (GO:0009303) | 4.62609865 |
| 34 | histone H4-K16 acetylation (GO:0043984) | 4.35070446 |
| 35 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.30792697 |
| 36 | notochord development (GO:0030903) | 4.28001220 |
| 37 | regulation of cilium movement (GO:0003352) | 4.25459778 |
| 38 | protein localization to endosome (GO:0036010) | 4.08742012 |
| 39 | pore complex assembly (GO:0046931) | 4.05741312 |
| 40 | mRNA stabilization (GO:0048255) | 3.99342316 |
| 41 | RNA stabilization (GO:0043489) | 3.99342316 |
| 42 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 3.98434126 |
| 43 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.95688813 |
| 44 | adherens junction assembly (GO:0034333) | 3.94816881 |
| 45 | focal adhesion assembly (GO:0048041) | 3.89833043 |
| 46 | cell-substrate adherens junction assembly (GO:0007045) | 3.89833043 |
| 47 | regulation of gene silencing by RNA (GO:0060966) | 3.86720051 |
| 48 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.86720051 |
| 49 | regulation of gene silencing by miRNA (GO:0060964) | 3.86720051 |
| 50 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.85684195 |
| 51 | hormone catabolic process (GO:0042447) | 3.84002702 |
| 52 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.81433595 |
| 53 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.75304598 |
| 54 | regulation of translation in response to stress (GO:0043555) | 3.73432544 |
| 55 | activation of Rac GTPase activity (GO:0032863) | 3.72202441 |
| 56 | positive regulation of histone deacetylation (GO:0031065) | 3.70992733 |
| 57 | proline biosynthetic process (GO:0006561) | 3.70719755 |
| 58 | regulation of hippo signaling (GO:0035330) | 3.69933172 |
| 59 | cytidine metabolic process (GO:0046087) | 3.69062838 |
| 60 | cytidine catabolic process (GO:0006216) | 3.69062838 |
| 61 | cytidine deamination (GO:0009972) | 3.69062838 |
| 62 | apoptotic process involved in morphogenesis (GO:0060561) | 3.67242763 |
| 63 | DNA duplex unwinding (GO:0032508) | 3.65894768 |
| 64 | trophectodermal cell differentiation (GO:0001829) | 3.64495493 |
| 65 | DNA replication checkpoint (GO:0000076) | 3.64125690 |
| 66 | positive regulation of protein deacetylation (GO:0090312) | 3.61226440 |
| 67 | DNA geometric change (GO:0032392) | 3.61045709 |
| 68 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.57966180 |
| 69 | mitotic chromosome condensation (GO:0007076) | 3.57617016 |
| 70 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.53631765 |
| 71 | rRNA methylation (GO:0031167) | 3.53334247 |
| 72 | NLS-bearing protein import into nucleus (GO:0006607) | 3.50281370 |
| 73 | primitive streak formation (GO:0090009) | 3.49265816 |
| 74 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 3.48039255 |
| 75 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.47854906 |
| 76 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.47786683 |
| 77 | maternal placenta development (GO:0001893) | 3.47508594 |
| 78 | interferon-gamma production (GO:0032609) | 3.46113478 |
| 79 | negative regulation of telomere maintenance (GO:0032205) | 3.45174889 |
| 80 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.44184084 |
| 81 | protein retention in ER lumen (GO:0006621) | 3.43626096 |
| 82 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.36681155 |
| 83 | maintenance of protein localization in organelle (GO:0072595) | 3.35817785 |
| 84 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 3.35762650 |
| 85 | intestinal epithelial cell development (GO:0060576) | 3.34134175 |
| 86 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.33741667 |
| 87 | cell-substrate junction assembly (GO:0007044) | 3.32875089 |
| 88 | nucleoside transmembrane transport (GO:1901642) | 3.30791158 |
| 89 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.30485128 |
| 90 | mannose metabolic process (GO:0006013) | 3.29574844 |
| 91 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.29279485 |
| 92 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.27577168 |
| 93 | retinoic acid receptor signaling pathway (GO:0048384) | 3.27130146 |
| 94 | microtubule severing (GO:0051013) | 3.24696203 |
| 95 | DNA unwinding involved in DNA replication (GO:0006268) | 3.24011101 |
| 96 | regulation of translational fidelity (GO:0006450) | 3.23845784 |
| 97 | embryonic process involved in female pregnancy (GO:0060136) | 3.23203209 |
| 98 | response to dietary excess (GO:0002021) | 3.18036018 |
| 99 | regulation of telomere maintenance (GO:0032204) | 3.16521368 |
| 100 | rRNA modification (GO:0000154) | 3.15971275 |
| 101 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.15596733 |
| 102 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.15564808 |
| 103 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.14338897 |
| 104 | regulation of early endosome to late endosome transport (GO:2000641) | 3.11491029 |
| 105 | pentose-phosphate shunt (GO:0006098) | 3.11217682 |
| 106 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.10416089 |
| 107 | spindle assembly (GO:0051225) | 3.09754537 |
| 108 | epithelial cell-cell adhesion (GO:0090136) | 3.08942754 |
| 109 | regulation of nucleobase-containing compound transport (GO:0032239) | 3.06650920 |
| 110 | chromosome condensation (GO:0030261) | 3.05685582 |
| 111 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.02290376 |
| 112 | semaphorin-plexin signaling pathway (GO:0071526) | 2.99146583 |
| 113 | phenol-containing compound catabolic process (GO:0019336) | 2.98009809 |
| 114 | cellular protein complex localization (GO:0034629) | 2.97649545 |
| 115 | protein polyglutamylation (GO:0018095) | 2.95110930 |
| 116 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.94228047 |
| 117 | ribosome biogenesis (GO:0042254) | 2.93477654 |
| 118 | regulation of RNA export from nucleus (GO:0046831) | 2.93199607 |
| 119 | transcription from mitochondrial promoter (GO:0006390) | 2.92805536 |
| 120 | mitochondrion distribution (GO:0048311) | 2.92161616 |
| 121 | DNA conformation change (GO:0071103) | 2.90638753 |
| 122 | pinocytosis (GO:0006907) | 2.89554485 |
| 123 | cellular modified amino acid catabolic process (GO:0042219) | 2.89519152 |
| 124 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.89459204 |
| 125 | negative regulation of cell size (GO:0045792) | 2.87420852 |
| 126 | cardiovascular system development (GO:0072358) | 2.87297343 |
| 127 | protein complex localization (GO:0031503) | 2.86757368 |
| 128 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.86067491 |
| 129 | regulation of histone H3-K27 methylation (GO:0061085) | 2.85753159 |
| 130 | apoptotic DNA fragmentation (GO:0006309) | 2.85347254 |
| 131 | positive regulation of nuclease activity (GO:0032075) | 2.84755240 |
| 132 | regulation of telomerase activity (GO:0051972) | 2.83725635 |
| 133 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.83319382 |
| 134 | hypotonic response (GO:0006971) | 2.82776755 |
| 135 | bone trabecula formation (GO:0060346) | 2.82421952 |
| 136 | basement membrane organization (GO:0071711) | 2.81564574 |
| 137 | cell migration involved in gastrulation (GO:0042074) | 2.81507597 |
| 138 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.81477737 |
| 139 | regulation of chromatin binding (GO:0035561) | 2.80693289 |
| 140 | regulation of double-strand break repair (GO:2000779) | 2.80597043 |
| 141 | stress fiber assembly (GO:0043149) | 2.80469784 |
| 142 | barbed-end actin filament capping (GO:0051016) | 2.77929515 |
| 143 | glucose 6-phosphate metabolic process (GO:0051156) | 2.76431948 |
| 144 | regulation of cholesterol homeostasis (GO:2000188) | 2.74960681 |
| 145 | cellular response to epidermal growth factor stimulus (GO:0071364) | 2.73012082 |
| 146 | negative regulation of fatty acid transport (GO:2000192) | 2.71873689 |
| 147 | glucose catabolic process (GO:0006007) | 2.70922000 |
| 148 | NADPH regeneration (GO:0006740) | 2.68157890 |
| 149 | protein export from nucleus (GO:0006611) | 2.67503423 |
| 150 | negative regulation of viral release from host cell (GO:1902187) | 2.65194433 |
| 151 | proline metabolic process (GO:0006560) | 2.60757658 |
| 152 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.59627938 |
| 153 | response to laminar fluid shear stress (GO:0034616) | 2.58509706 |
| 154 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.56731229 |
| 155 | regulation of nuclease activity (GO:0032069) | 2.56531884 |
| 156 | negative regulation of myotube differentiation (GO:0010832) | 2.54987994 |
| 157 | urea cycle (GO:0000050) | 2.54657784 |
| 158 | desmosome organization (GO:0002934) | 2.54066319 |
| 159 | ER-nucleus signaling pathway (GO:0006984) | 2.52033920 |
| 160 | histone H3-K36 demethylation (GO:0070544) | 2.51236196 |
| 161 | cellular hyperosmotic response (GO:0071474) | 2.49670600 |
| 162 | peptidyl-lysine dimethylation (GO:0018027) | 2.49581380 |
| 163 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.46491487 |
| 164 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.45960037 |
| 165 | hemidesmosome assembly (GO:0031581) | 2.44952547 |
| 166 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.43679033 |
| 167 | modulation by symbiont of host cellular process (GO:0044068) | 2.43096702 |
| 168 | protein-DNA complex disassembly (GO:0032986) | 2.42753270 |
| 169 | nucleosome disassembly (GO:0006337) | 2.42753270 |
| 170 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.42504456 |
| 171 | vesicle coating (GO:0006901) | 2.42159652 |
| 172 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.41815373 |
| 173 | amyloid precursor protein catabolic process (GO:0042987) | 2.38339345 |
| 174 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.36300028 |
| 175 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.35742789 |
| 176 | response to epidermal growth factor (GO:0070849) | 2.35263939 |
| 177 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.33619298 |
| 178 | urea metabolic process (GO:0019627) | 2.33201990 |
| 179 | cellular response to unfolded protein (GO:0034620) | 2.33023076 |
| 180 | skin morphogenesis (GO:0043589) | 2.28967986 |
| 181 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.27949340 |
| 182 | negative regulation of necroptotic process (GO:0060546) | 2.27428590 |
| 183 | activation of MAPKKK activity (GO:0000185) | 2.26005057 |
| 184 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.25730606 |
| 185 | NADH metabolic process (GO:0006734) | 2.23670991 |
| 186 | positive regulation of receptor recycling (GO:0001921) | 2.23645067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.60737254 |
| 2 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.42183503 |
| 3 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.42183503 |
| 4 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.42183503 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.19642824 |
| 6 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.20377188 |
| 7 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 3.04712059 |
| 8 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.00084045 |
| 9 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.96106706 |
| 10 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.84821534 |
| 11 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.74765227 |
| 12 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 2.67371654 |
| 13 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.66284978 |
| 14 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.54643930 |
| 15 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.52969358 |
| 16 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.29258378 |
| 17 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.20907510 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.20473645 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.16795281 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.16517230 |
| 21 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 2.11353946 |
| 22 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.11197508 |
| 23 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.09216437 |
| 24 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.07681248 |
| 25 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.05760739 |
| 26 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.91088950 |
| 27 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.88377270 |
| 28 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.84996528 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.82180164 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.79457335 |
| 31 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.78699180 |
| 32 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.77326173 |
| 33 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.76433141 |
| 34 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.73933955 |
| 35 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71675163 |
| 36 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.70677763 |
| 37 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.69274362 |
| 38 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.69127390 |
| 39 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.67690824 |
| 40 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.66750639 |
| 41 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.66509950 |
| 42 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.64053669 |
| 43 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.63842269 |
| 44 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.63566141 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60269914 |
| 46 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.59839010 |
| 47 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.58926728 |
| 48 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.58924355 |
| 49 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.57877151 |
| 50 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.50407469 |
| 51 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48890827 |
| 52 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.45271166 |
| 53 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.44815313 |
| 54 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44814148 |
| 55 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.43038289 |
| 56 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.42909939 |
| 57 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.41396314 |
| 58 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.41229258 |
| 59 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.39752971 |
| 60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37372975 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.37307184 |
| 62 | NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.36737857 |
| 63 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.36373966 |
| 64 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.35161004 |
| 65 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.34938717 |
| 66 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34566404 |
| 67 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.34530281 |
| 68 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.34493918 |
| 69 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.34158952 |
| 70 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32977839 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.32732142 |
| 72 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.32358800 |
| 73 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.31530678 |
| 74 | MAF_26560356_Chip-Seq_TH1_Human | 1.31029193 |
| 75 | SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.29935899 |
| 76 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.29630988 |
| 77 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.29590016 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29336062 |
| 79 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.28159205 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.28119380 |
| 81 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.26682921 |
| 82 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.26355165 |
| 83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.25788272 |
| 84 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25098421 |
| 85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24522694 |
| 86 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23584694 |
| 87 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.22690121 |
| 88 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.21958123 |
| 89 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.20998726 |
| 90 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.20859729 |
| 91 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.20672757 |
| 92 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.19490371 |
| 93 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.14980595 |
| 94 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.14554314 |
| 95 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.14509354 |
| 96 | * MAF_26560356_Chip-Seq_TH2_Human | 1.12958911 |
| 97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12516824 |
| 98 | E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.12401227 |
| 99 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12287947 |
| 100 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.10348538 |
| 101 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.09706023 |
| 102 | UTX_26944678_Chip-Seq_JUKART_Human | 1.09170638 |
| 103 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.08725156 |
| 104 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.08440519 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.08129252 |
| 106 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.07995091 |
| 107 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.06849918 |
| 108 | NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.06625408 |
| 109 | * XRN2_22483619_ChIP-Seq_HELA_Human | 1.05809232 |
| 110 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05060136 |
| 111 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.05026861 |
| 112 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04433557 |
| 113 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.04229772 |
| 114 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.04021865 |
| 115 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03610494 |
| 116 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.03128946 |
| 117 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.02006312 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.01651212 |
| 119 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01251256 |
| 120 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00770617 |
| 121 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.00306816 |
| 122 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99964165 |
| 123 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.99624237 |
| 124 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.98916986 |
| 125 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98225659 |
| 126 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.97682333 |
| 127 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95905222 |
| 128 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95866114 |
| 129 | P68_20966046_ChIP-Seq_HELA_Human | 0.95821283 |
| 130 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.95542531 |
| 131 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95356194 |
| 132 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.95276443 |
| 133 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.95123700 |
| 134 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95014010 |
| 135 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.94393815 |
| 136 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93982882 |
| 137 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.90820556 |
| 138 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90512826 |
| 139 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.86441345 |
| 140 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.85495177 |
| 141 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.84812304 |
| 142 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.83854894 |
| 143 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83488103 |
| 144 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.83316005 |
| 145 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.82907706 |
| 146 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.82747878 |
| 147 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.82261847 |
| 148 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.81826316 |
| 149 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 0.81067494 |
| 150 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.81062407 |
| 151 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.80648910 |
| 152 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.80534553 |
| 153 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79246335 |
| 154 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.78999000 |
| 155 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.78570874 |
| 156 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.78462495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004264_abnormal_extraembryonic_tissu | 3.92826480 |
| 2 | MP0005451_abnormal_body_composition | 3.73540246 |
| 3 | MP0002254_reproductive_system_inflammat | 3.39932601 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.39269082 |
| 5 | MP0003890_abnormal_embryonic-extraembry | 3.38055346 |
| 6 | MP0003011_delayed_dark_adaptation | 3.30633715 |
| 7 | MP0008057_abnormal_DNA_replication | 3.16617730 |
| 8 | MP0006292_abnormal_olfactory_placode | 2.96480145 |
| 9 | MP0004858_abnormal_nervous_system | 2.89992852 |
| 10 | MP0005499_abnormal_olfactory_system | 2.88190698 |
| 11 | MP0005394_taste/olfaction_phenotype | 2.88190698 |
| 12 | MP0004957_abnormal_blastocyst_morpholog | 2.87822016 |
| 13 | MP0010352_gastrointestinal_tract_polyps | 2.85600377 |
| 14 | MP0010234_abnormal_vibrissa_follicle | 2.73919173 |
| 15 | MP0004185_abnormal_adipocyte_glucose | 2.58624321 |
| 16 | MP0002653_abnormal_ependyma_morphology | 2.54461045 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.49760845 |
| 18 | MP0008260_abnormal_autophagy | 2.44285008 |
| 19 | MP0003122_maternal_imprinting | 2.29477432 |
| 20 | MP0004233_abnormal_muscle_weight | 2.26936009 |
| 21 | MP0005075_abnormal_melanosome_morpholog | 2.22893411 |
| 22 | MP0002332_abnormal_exercise_endurance | 2.21941608 |
| 23 | MP0009840_abnormal_foam_cell | 2.21276662 |
| 24 | MP0001672_abnormal_embryogenesis/_devel | 2.20631819 |
| 25 | MP0005380_embryogenesis_phenotype | 2.20631819 |
| 26 | MP0003121_genomic_imprinting | 2.20221670 |
| 27 | MP0005257_abnormal_intraocular_pressure | 2.13192928 |
| 28 | MP0002088_abnormal_embryonic_growth/wei | 2.04166532 |
| 29 | MP0003984_embryonic_growth_retardation | 2.03788977 |
| 30 | MP0008961_abnormal_basal_metabolism | 2.02938923 |
| 31 | MP0003111_abnormal_nucleus_morphology | 2.00652471 |
| 32 | MP0003453_abnormal_keratinocyte_physiol | 1.96154845 |
| 33 | MP0003077_abnormal_cell_cycle | 1.87097442 |
| 34 | MP0001849_ear_inflammation | 1.81739252 |
| 35 | MP0000350_abnormal_cell_proliferation | 1.80958218 |
| 36 | MP0010030_abnormal_orbit_morphology | 1.80633452 |
| 37 | MP0005409_darkened_coat_color | 1.79748346 |
| 38 | MP0003191_abnormal_cellular_cholesterol | 1.79661875 |
| 39 | MP0003091_abnormal_cell_migration | 1.77570892 |
| 40 | MP0006035_abnormal_mitochondrial_morpho | 1.75608410 |
| 41 | MP0002796_impaired_skin_barrier | 1.74713231 |
| 42 | MP0000537_abnormal_urethra_morphology | 1.71756997 |
| 43 | MP0002086_abnormal_extraembryonic_tissu | 1.68046863 |
| 44 | MP0003123_paternal_imprinting | 1.66285773 |
| 45 | MP0000678_abnormal_parathyroid_gland | 1.63438938 |
| 46 | MP0002085_abnormal_embryonic_tissue | 1.62420532 |
| 47 | MP0001293_anophthalmia | 1.62218294 |
| 48 | MP0010094_abnormal_chromosome_stability | 1.60700487 |
| 49 | MP0002084_abnormal_developmental_patter | 1.58385908 |
| 50 | MP0003300_gastrointestinal_ulcer | 1.56978174 |
| 51 | MP0000751_myopathy | 1.55273936 |
| 52 | MP0008438_abnormal_cutaneous_collagen | 1.54239119 |
| 53 | MP0005666_abnormal_adipose_tissue | 1.54182100 |
| 54 | MP0009672_abnormal_birth_weight | 1.52185283 |
| 55 | MP0004197_abnormal_fetal_growth/weight/ | 1.51683081 |
| 56 | MP0001730_embryonic_growth_arrest | 1.51133742 |
| 57 | MP0002127_abnormal_cardiovascular_syste | 1.47026276 |
| 58 | MP0002092_abnormal_eye_morphology | 1.45915484 |
| 59 | MP0000858_altered_metastatic_potential | 1.45109933 |
| 60 | MP0009278_abnormal_bone_marrow | 1.44603226 |
| 61 | MP0000003_abnormal_adipose_tissue | 1.41587984 |
| 62 | MP0003172_abnormal_lysosome_physiology | 1.40165965 |
| 63 | MP0002089_abnormal_postnatal_growth/wei | 1.37923493 |
| 64 | MP0003938_abnormal_ear_development | 1.37388065 |
| 65 | MP0005501_abnormal_skin_physiology | 1.35485730 |
| 66 | MP0003283_abnormal_digestive_organ | 1.34950590 |
| 67 | MP0002932_abnormal_joint_morphology | 1.33918458 |
| 68 | MP0005375_adipose_tissue_phenotype | 1.32165889 |
| 69 | MP0004272_abnormal_basement_membrane | 1.30554579 |
| 70 | MP0003119_abnormal_digestive_system | 1.28903761 |
| 71 | MP0000747_muscle_weakness | 1.26864856 |
| 72 | MP0001697_abnormal_embryo_size | 1.26562273 |
| 73 | MP0000428_abnormal_craniofacial_morphol | 1.26082127 |
| 74 | MP0004947_skin_inflammation | 1.24390816 |
| 75 | MP0002396_abnormal_hematopoietic_system | 1.23494336 |
| 76 | MP0003329_amyloid_beta_deposits | 1.21540369 |
| 77 | MP0005621_abnormal_cell_physiology | 1.20797355 |
| 78 | MP0002080_prenatal_lethality | 1.18845761 |
| 79 | MP0002249_abnormal_larynx_morphology | 1.18592128 |
| 80 | MP0001348_abnormal_lacrimal_gland | 1.18360122 |
| 81 | MP0008770_decreased_survivor_rate | 1.17657925 |
| 82 | MP0003303_peritoneal_inflammation | 1.17280840 |
| 83 | MP0002060_abnormal_skin_morphology | 1.15116275 |
| 84 | MP0001915_intracranial_hemorrhage | 1.14944632 |
| 85 | MP0002269_muscular_atrophy | 1.14902636 |
| 86 | MP0003935_abnormal_craniofacial_develop | 1.13380555 |
| 87 | MP0004087_abnormal_muscle_fiber | 1.12993978 |
| 88 | MP0004808_abnormal_hematopoietic_stem | 1.12851973 |
| 89 | MP0003436_decreased_susceptibility_to | 1.11176354 |
| 90 | MP0005623_abnormal_meninges_morphology | 1.11035079 |
| 91 | MP0005410_abnormal_fertilization | 1.09616797 |
| 92 | MP0000432_abnormal_head_morphology | 1.07746390 |
| 93 | MP0004133_heterotaxia | 1.07528975 |
| 94 | MP0002114_abnormal_axial_skeleton | 1.07180905 |
| 95 | MP0000762_abnormal_tongue_morphology | 1.06853487 |
| 96 | MP0000313_abnormal_cell_death | 1.05846639 |
| 97 | MP0003693_abnormal_embryo_hatching | 1.05480495 |
| 98 | MP0002925_abnormal_cardiovascular_devel | 1.04064574 |
| 99 | MP0000750_abnormal_muscle_regeneration | 1.03591013 |
| 100 | MP0002970_abnormal_white_adipose | 1.02690378 |
| 101 | MP0005266_abnormal_metabolism | 1.02175946 |
| 102 | MP0003787_abnormal_imprinting | 1.02169222 |
| 103 | MP0003183_abnormal_peptide_metabolism | 1.02003939 |
| 104 | MP0001661_extended_life_span | 1.01730463 |
| 105 | MP0008789_abnormal_olfactory_epithelium | 1.00853952 |
| 106 | MP0004510_myositis | 0.99991397 |
| 107 | MP0002233_abnormal_nose_morphology | 0.99721173 |
| 108 | MP0009703_decreased_birth_body | 0.98560226 |
| 109 | MP0005076_abnormal_cell_differentiation | 0.95651063 |
| 110 | MP0000049_abnormal_middle_ear | 0.94758054 |
| 111 | MP0000490_abnormal_crypts_of | 0.94726599 |
| 112 | MP0002877_abnormal_melanocyte_morpholog | 0.94603922 |
| 113 | MP0003137_abnormal_impulse_conducting | 0.94275464 |
| 114 | MP0008007_abnormal_cellular_replicative | 0.93956106 |
| 115 | MP0002009_preneoplasia | 0.93632994 |
| 116 | MP0008932_abnormal_embryonic_tissue | 0.93232203 |
| 117 | MP0002277_abnormal_respiratory_mucosa | 0.92270758 |
| 118 | MP0005023_abnormal_wound_healing | 0.92024116 |
| 119 | MP0001216_abnormal_epidermal_layer | 0.90800297 |
| 120 | MP0003755_abnormal_palate_morphology | 0.90558942 |
| 121 | MP0003115_abnormal_respiratory_system | 0.90003314 |
| 122 | MP0009333_abnormal_splenocyte_physiolog | 0.87523246 |
| 123 | MP0000467_abnormal_esophagus_morphology | 0.85147444 |
| 124 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83822732 |
| 125 | MP0005248_abnormal_Harderian_gland | 0.82888598 |
| 126 | MP0002098_abnormal_vibrissa_morphology | 0.82742451 |
| 127 | MP0003566_abnormal_cell_adhesion | 0.81695865 |
| 128 | MP0009931_abnormal_skin_appearance | 0.81379824 |
| 129 | MP0001346_abnormal_lacrimal_gland | 0.81379434 |
| 130 | MP0006082_CNS_inflammation | 0.81124261 |
| 131 | MP0005330_cardiomyopathy | 0.79546357 |
| 132 | MP0005391_vision/eye_phenotype | 0.78720540 |
| 133 | MP0006138_congestive_heart_failure | 0.78173349 |
| 134 | MP0000749_muscle_degeneration | 0.76509922 |
| 135 | MP0009053_abnormal_anal_canal | 0.76146894 |
| 136 | MP0000358_abnormal_cell_content/ | 0.75355503 |
| 137 | MP0003861_abnormal_nervous_system | 0.74718025 |
| 138 | MP0000579_abnormal_nail_morphology | 0.74298941 |
| 139 | MP0002896_abnormal_bone_mineralization | 0.74131366 |
| 140 | MP0002998_abnormal_bone_remodeling | 0.73876536 |
| 141 | MP0003634_abnormal_glial_cell | 0.73429665 |
| 142 | MP0002116_abnormal_craniofacial_bone | 0.73187668 |
| 143 | MP0010630_abnormal_cardiac_muscle | 0.72840392 |
| 144 | MP0010307_abnormal_tumor_latency | 0.71293056 |
| 145 | MP0000377_abnormal_hair_follicle | 0.71107474 |
| 146 | MP0001873_stomach_inflammation | 0.71077565 |
| 147 | MP0000477_abnormal_intestine_morphology | 0.70813131 |
| 148 | MP0005384_cellular_phenotype | 0.69963322 |
| 149 | MP0003763_abnormal_thymus_physiology | 0.69263543 |
| 150 | MP0002111_abnormal_tail_morphology | 0.67886800 |
| 151 | MP0002697_abnormal_eye_size | 0.67415825 |
| 152 | MP0000266_abnormal_heart_morphology | 0.66715793 |
| 153 | MP0002081_perinatal_lethality | 0.66595838 |
| 154 | MP0000759_abnormal_skeletal_muscle | 0.65566337 |
| 155 | MP0000733_abnormal_muscle_development | 0.65212217 |
| 156 | MP0005508_abnormal_skeleton_morphology | 0.64305900 |
| 157 | MP0004043_abnormal_pH_regulation | 0.64160632 |
| 158 | MP0002019_abnormal_tumor_incidence | 0.63748708 |
| 159 | MP0003937_abnormal_limbs/digits/tail_de | 0.63648835 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 6.33799032 |
| 2 | Hypochromic microcytic anemia (HP:0004840) | 5.46039650 |
| 3 | Abnormality of the lower motor neuron (HP:0002366) | 5.37486821 |
| 4 | Ependymoma (HP:0002888) | 4.88493556 |
| 5 | Hepatoblastoma (HP:0002884) | 4.60832925 |
| 6 | Multiple enchondromatosis (HP:0005701) | 4.60324944 |
| 7 | Rib fusion (HP:0000902) | 4.48529764 |
| 8 | Neoplasm of striated muscle (HP:0009728) | 3.83526225 |
| 9 | Abnormality of the astrocytes (HP:0100707) | 3.74566439 |
| 10 | Astrocytoma (HP:0009592) | 3.74566439 |
| 11 | Hyperacusis (HP:0010780) | 3.73390275 |
| 12 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.50913974 |
| 13 | Rhabdomyosarcoma (HP:0002859) | 3.49750555 |
| 14 | Distal lower limb amyotrophy (HP:0008944) | 3.28734949 |
| 15 | Nephroblastoma (Wilms tumor) (HP:0002667) | 3.11958502 |
| 16 | Amyotrophic lateral sclerosis (HP:0007354) | 3.07565611 |
| 17 | Testicular atrophy (HP:0000029) | 3.04900370 |
| 18 | Short humerus (HP:0005792) | 2.99396949 |
| 19 | Chromsome breakage (HP:0040012) | 2.97952246 |
| 20 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.91295821 |
| 21 | Flat acetabular roof (HP:0003180) | 2.88970369 |
| 22 | Embryonal renal neoplasm (HP:0011794) | 2.86903052 |
| 23 | Rectal fistula (HP:0100590) | 2.86158191 |
| 24 | Rectovaginal fistula (HP:0000143) | 2.86158191 |
| 25 | Abnormality of the salivary glands (HP:0010286) | 2.85776923 |
| 26 | Broad face (HP:0000283) | 2.83869745 |
| 27 | Fused cervical vertebrae (HP:0002949) | 2.81962957 |
| 28 | Intestinal fistula (HP:0100819) | 2.81258574 |
| 29 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.80536922 |
| 30 | Difficulty running (HP:0009046) | 2.77244765 |
| 31 | Glioma (HP:0009733) | 2.74253731 |
| 32 | Increased connective tissue (HP:0009025) | 2.74127080 |
| 33 | Renal duplication (HP:0000075) | 2.71086413 |
| 34 | Hand muscle atrophy (HP:0009130) | 2.69509608 |
| 35 | Distal lower limb muscle weakness (HP:0009053) | 2.62947275 |
| 36 | Cerebral aneurysm (HP:0004944) | 2.62038299 |
| 37 | Preauricular skin tag (HP:0000384) | 2.61621070 |
| 38 | Vertebral compression fractures (HP:0002953) | 2.61569058 |
| 39 | Neoplasm of the heart (HP:0100544) | 2.56099696 |
| 40 | Protrusio acetabuli (HP:0003179) | 2.54943415 |
| 41 | Hypopigmentation of the fundus (HP:0007894) | 2.54572910 |
| 42 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.53370236 |
| 43 | Premature rupture of membranes (HP:0001788) | 2.52844656 |
| 44 | Impulsivity (HP:0100710) | 2.51639426 |
| 45 | Pseudobulbar signs (HP:0002200) | 2.51485008 |
| 46 | Trismus (HP:0000211) | 2.50688134 |
| 47 | Skin tags (HP:0010609) | 2.49789627 |
| 48 | Lower limb amyotrophy (HP:0007210) | 2.47409611 |
| 49 | Bifid tongue (HP:0010297) | 2.46516598 |
| 50 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.45486277 |
| 51 | Hypoplasia of the fovea (HP:0007750) | 2.45486277 |
| 52 | Ragged-red muscle fibers (HP:0003200) | 2.45229465 |
| 53 | Resting tremor (HP:0002322) | 2.44879062 |
| 54 | Vaginal fistula (HP:0004320) | 2.43337920 |
| 55 | Distal upper limb amyotrophy (HP:0007149) | 2.42990703 |
| 56 | Upper limb amyotrophy (HP:0009129) | 2.42990703 |
| 57 | Large earlobe (HP:0009748) | 2.42710394 |
| 58 | Partial duplication of thumb phalanx (HP:0009944) | 2.40552565 |
| 59 | Abnormality of chromosome segregation (HP:0002916) | 2.36524433 |
| 60 | Hypochromic anemia (HP:0001931) | 2.35898507 |
| 61 | Horizontal nystagmus (HP:0000666) | 2.35391671 |
| 62 | Asymmetry of the thorax (HP:0001555) | 2.34487721 |
| 63 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.33111979 |
| 64 | Abnormal lung lobation (HP:0002101) | 2.32382068 |
| 65 | Meckel diverticulum (HP:0002245) | 2.31977570 |
| 66 | Dysmetric saccades (HP:0000641) | 2.31198823 |
| 67 | Generalized hypotonia (HP:0001290) | 2.31121690 |
| 68 | Abnormal cartilage morphology (HP:0002763) | 2.30863929 |
| 69 | Deep venous thrombosis (HP:0002625) | 2.29717345 |
| 70 | Shawl scrotum (HP:0000049) | 2.28245677 |
| 71 | Insomnia (HP:0100785) | 2.25027750 |
| 72 | Abnormality of the musculature of the hand (HP:0001421) | 2.23678427 |
| 73 | Disproportionate tall stature (HP:0001519) | 2.20889408 |
| 74 | Long palpebral fissure (HP:0000637) | 2.19843147 |
| 75 | Short 5th finger (HP:0009237) | 2.19619941 |
| 76 | Abnormality of the ileum (HP:0001549) | 2.18434785 |
| 77 | Preauricular pit (HP:0004467) | 2.18373216 |
| 78 | Periauricular skin pits (HP:0100277) | 2.18373216 |
| 79 | Thin bony cortex (HP:0002753) | 2.17847689 |
| 80 | Upper motor neuron abnormality (HP:0002127) | 2.16412680 |
| 81 | Progressive muscle weakness (HP:0003323) | 2.16200651 |
| 82 | Achilles tendon contracture (HP:0001771) | 2.16122983 |
| 83 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.14442519 |
| 84 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12491522 |
| 85 | Medulloblastoma (HP:0002885) | 2.12179431 |
| 86 | Partial duplication of the phalanx of hand (HP:0009999) | 2.10913552 |
| 87 | Ankyloglossia (HP:0010296) | 2.10055488 |
| 88 | Abnormality of the pubic bones (HP:0003172) | 2.09976070 |
| 89 | Missing ribs (HP:0000921) | 2.09431711 |
| 90 | Obstructive sleep apnea (HP:0002870) | 2.09182552 |
| 91 | Nasal polyposis (HP:0100582) | 2.07795070 |
| 92 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.06866395 |
| 93 | Difficulty climbing stairs (HP:0003551) | 2.06364192 |
| 94 | EMG: neuropathic changes (HP:0003445) | 2.06125589 |
| 95 | Vertebral fusion (HP:0002948) | 2.02192462 |
| 96 | Tetraplegia (HP:0002445) | 2.01839179 |
| 97 | Anomalous pulmonary venous return (HP:0010772) | 2.01816072 |
| 98 | Adenoma sebaceum (HP:0009720) | 2.01279394 |
| 99 | Angiofibromas (HP:0010615) | 2.01279394 |
| 100 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.00797992 |
| 101 | Hemorrhage of the eye (HP:0011885) | 1.99328579 |
| 102 | Aplasia/Hypoplasia of the 5th finger (HP:0006262) | 1.99013615 |
| 103 | Advanced eruption of teeth (HP:0006288) | 1.97706270 |
| 104 | Short nail (HP:0001799) | 1.97556371 |
| 105 | Cervical subluxation (HP:0003308) | 1.93605676 |
| 106 | Cerebral inclusion bodies (HP:0100314) | 1.93119355 |
| 107 | Abnormality of the fingertips (HP:0001211) | 1.93056947 |
| 108 | Shallow orbits (HP:0000586) | 1.92658783 |
| 109 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.92205956 |
| 110 | Increased variability in muscle fiber diameter (HP:0003557) | 1.91858615 |
| 111 | Myopathic facies (HP:0002058) | 1.91478750 |
| 112 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.91015143 |
| 113 | Abnormality of the Achilles tendon (HP:0005109) | 1.91006509 |
| 114 | Abnormality of oral frenula (HP:0000190) | 1.90441083 |
| 115 | Ulnar bowing (HP:0003031) | 1.89474689 |
| 116 | Spinal muscular atrophy (HP:0007269) | 1.89404162 |
| 117 | Back pain (HP:0003418) | 1.89027644 |
| 118 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.88992992 |
| 119 | Neoplasm of the oral cavity (HP:0100649) | 1.88109027 |
| 120 | Supernumerary ribs (HP:0005815) | 1.87905432 |
| 121 | Selective tooth agenesis (HP:0001592) | 1.87826673 |
| 122 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.87489616 |
| 123 | Skin pits (HP:0100276) | 1.87103939 |
| 124 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.86171713 |
| 125 | Prominent occiput (HP:0000269) | 1.86102513 |
| 126 | Small intestinal stenosis (HP:0012848) | 1.85999783 |
| 127 | Duodenal stenosis (HP:0100867) | 1.85999783 |
| 128 | Supernumerary spleens (HP:0009799) | 1.84674002 |
| 129 | Metaphyseal cupping (HP:0003021) | 1.84528935 |
| 130 | Abnormality of the thoracic spine (HP:0100711) | 1.83319574 |
| 131 | Upper limb muscle weakness (HP:0003484) | 1.82961585 |
| 132 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.82236963 |
| 133 | Stridor (HP:0010307) | 1.80583784 |
| 134 | Increased nuchal translucency (HP:0010880) | 1.80220188 |
| 135 | Cholecystitis (HP:0001082) | 1.79467057 |
| 136 | Abnormal gallbladder physiology (HP:0012438) | 1.79467057 |
| 137 | Progressive external ophthalmoplegia (HP:0000590) | 1.78581537 |
| 138 | Tongue fasciculations (HP:0001308) | 1.78460720 |
| 139 | Aneurysm (HP:0002617) | 1.77169652 |
| 140 | Fragile skin (HP:0001030) | 1.76381959 |
| 141 | Muscle fibrillation (HP:0010546) | 1.76180567 |
| 142 | Heterotopia (HP:0002282) | 1.75968127 |
| 143 | Syringomyelia (HP:0003396) | 1.75605197 |
| 144 | Spinal cord lesions (HP:0100561) | 1.75605197 |
| 145 | Abnormality of the calcaneus (HP:0008364) | 1.74719105 |
| 146 | Mitral regurgitation (HP:0001653) | 1.74675367 |
| 147 | Pointed chin (HP:0000307) | 1.73898872 |
| 148 | Biconcave vertebral bodies (HP:0004586) | 1.73716062 |
| 149 | Sparse lateral eyebrow (HP:0005338) | 1.72864484 |
| 150 | Patellar dislocation (HP:0002999) | 1.72753292 |
| 151 | Spinal rigidity (HP:0003306) | 1.72634697 |
| 152 | Osteolytic defects of the hand bones (HP:0009699) | 1.70873785 |
| 153 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.70873785 |
| 154 | Termporal pattern (HP:0011008) | 1.70416221 |
| 155 | Insidious onset (HP:0003587) | 1.70416221 |
| 156 | Reticulocytosis (HP:0001923) | 1.69146931 |
| 157 | Exercise-induced myalgia (HP:0003738) | 1.69063817 |
| 158 | Abnormal ossification of hand bones (HP:0005921) | 1.68709935 |
| 159 | Natal tooth (HP:0000695) | 1.67366147 |
| 160 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.64788833 |
| 161 | Abnormality of carpal bone ossification (HP:0006257) | 1.63973303 |
| 162 | Cellulitis (HP:0100658) | 1.63348446 |
| 163 | Blue sclerae (HP:0000592) | 1.62520197 |
| 164 | Colitis (HP:0002583) | 1.61800727 |
| 165 | Turricephaly (HP:0000262) | 1.61300217 |
| 166 | Broad distal phalanx of finger (HP:0009836) | 1.60962248 |
| 167 | Interstitial pulmonary disease (HP:0006530) | 1.60008460 |
| 168 | Arnold-Chiari malformation (HP:0002308) | 1.57979665 |
| 169 | Distal sensory impairment (HP:0002936) | 1.57922312 |
| 170 | Deviation of the thumb (HP:0009603) | 1.57578408 |
| 171 | Bowel incontinence (HP:0002607) | 1.57030240 |
| 172 | Hammertoe (HP:0001765) | 1.56890807 |
| 173 | Dislocated radial head (HP:0003083) | 1.56752013 |
| 174 | Bone pain (HP:0002653) | 1.55544653 |
| 175 | Hyperparathyroidism (HP:0000843) | 1.54961988 |
| 176 | Myocardial infarction (HP:0001658) | 1.53137975 |
| 177 | Subacute progressive viral hepatitis (HP:0006572) | 1.53084276 |
| 178 | Deep palmar crease (HP:0006191) | 1.52903545 |
| 179 | Overriding aorta (HP:0002623) | 1.52501474 |
| 180 | Germ cell neoplasia (HP:0100728) | 1.51159000 |
| 181 | Abnormal large intestine physiology (HP:0012700) | 1.51122426 |
| 182 | Onion bulb formation (HP:0003383) | 1.49967683 |
| 183 | Atrophic scars (HP:0001075) | 1.49188337 |
| 184 | Premature skin wrinkling (HP:0100678) | 1.49067673 |
| 185 | Thin ribs (HP:0000883) | 1.48766419 |
| 186 | Right ventricular cardiomyopathy (HP:0011663) | 1.48742928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 8.50705273 |
| 2 | GRK5 | 4.04583066 |
| 3 | ERN1 | 3.99689764 |
| 4 | GRK6 | 3.88383717 |
| 5 | SMG1 | 3.88110015 |
| 6 | PRPF4B | 3.10732716 |
| 7 | IRAK3 | 2.99121604 |
| 8 | TYRO3 | 2.76259428 |
| 9 | TTK | 2.59676406 |
| 10 | CSF1R | 2.37794837 |
| 11 | GRK1 | 2.29624279 |
| 12 | FGFR4 | 2.20833856 |
| 13 | STK10 | 2.13142612 |
| 14 | MAP3K10 | 2.08297128 |
| 15 | TGFBR2 | 2.01378126 |
| 16 | ADRBK2 | 1.94619915 |
| 17 | WNK1 | 1.87414034 |
| 18 | MAPK7 | 1.84817322 |
| 19 | MST1R | 1.79153237 |
| 20 | EPHA2 | 1.74759579 |
| 21 | NME2 | 1.74143282 |
| 22 | MATK | 1.73293913 |
| 23 | CDK7 | 1.51736694 |
| 24 | ICK | 1.47765456 |
| 25 | NEK2 | 1.42256328 |
| 26 | MOS | 1.39087170 |
| 27 | ALK | 1.36482199 |
| 28 | TRIB3 | 1.36264492 |
| 29 | GRK7 | 1.36241546 |
| 30 | MAP2K3 | 1.31345449 |
| 31 | PAK4 | 1.31141921 |
| 32 | CAMK4 | 1.26830041 |
| 33 | CDC7 | 1.26256996 |
| 34 | CHEK2 | 1.22979023 |
| 35 | MARK2 | 1.22887545 |
| 36 | NTRK1 | 1.19698384 |
| 37 | KSR2 | 1.18665887 |
| 38 | EPHB1 | 1.13223470 |
| 39 | TAOK2 | 1.12874191 |
| 40 | PRKG2 | 1.12584320 |
| 41 | SCYL2 | 1.11667576 |
| 42 | PLK1 | 1.09951856 |
| 43 | MTOR | 1.04050881 |
| 44 | PTK6 | 1.03925798 |
| 45 | EEF2K | 1.03659315 |
| 46 | FGFR3 | 1.03573727 |
| 47 | CHEK1 | 1.01847810 |
| 48 | LATS2 | 0.98136168 |
| 49 | LMTK2 | 0.92541910 |
| 50 | MAP3K13 | 0.92462830 |
| 51 | IRAK2 | 0.90977683 |
| 52 | HIPK2 | 0.90449957 |
| 53 | CDC42BPA | 0.90313824 |
| 54 | RIPK1 | 0.89265463 |
| 55 | PDGFRA | 0.89049454 |
| 56 | PKN2 | 0.87132830 |
| 57 | MAP3K3 | 0.85473319 |
| 58 | AKT2 | 0.85062970 |
| 59 | MET | 0.84223209 |
| 60 | BMX | 0.84136492 |
| 61 | MAP3K1 | 0.82422589 |
| 62 | TTN | 0.82330413 |
| 63 | MAP3K7 | 0.82316637 |
| 64 | MAPK11 | 0.82007219 |
| 65 | TESK1 | 0.81760179 |
| 66 | PDK4 | 0.81093412 |
| 67 | PDK3 | 0.81093412 |
| 68 | NEK1 | 0.80344881 |
| 69 | RPS6KB2 | 0.78938012 |
| 70 | PRKD3 | 0.77962097 |
| 71 | MAP3K6 | 0.76945880 |
| 72 | MAP3K11 | 0.76319618 |
| 73 | TESK2 | 0.76168623 |
| 74 | PDPK1 | 0.76109607 |
| 75 | MAP2K4 | 0.75588355 |
| 76 | CDK4 | 0.74216874 |
| 77 | CDK6 | 0.72046021 |
| 78 | STK38 | 0.71705379 |
| 79 | AKT3 | 0.68737565 |
| 80 | CAMK1G | 0.68034496 |
| 81 | CSK | 0.67547740 |
| 82 | SIK3 | 0.67492384 |
| 83 | RPS6KA2 | 0.66612509 |
| 84 | ADRBK1 | 0.65507141 |
| 85 | CDK2 | 0.65080922 |
| 86 | SIK2 | 0.64228266 |
| 87 | RET | 0.62360389 |
| 88 | IRAK4 | 0.62119365 |
| 89 | ARAF | 0.59994670 |
| 90 | RPS6KL1 | 0.55989547 |
| 91 | RPS6KC1 | 0.55989547 |
| 92 | MAP3K14 | 0.55805719 |
| 93 | TBK1 | 0.55554135 |
| 94 | MAP3K9 | 0.55525180 |
| 95 | DDR2 | 0.55179077 |
| 96 | BRD4 | 0.55150633 |
| 97 | LATS1 | 0.54775830 |
| 98 | TAOK1 | 0.54627767 |
| 99 | PTK2 | 0.51692712 |
| 100 | BRAF | 0.50570181 |
| 101 | LRRK2 | 0.50315476 |
| 102 | MAP4K1 | 0.49854796 |
| 103 | ATM | 0.48971019 |
| 104 | MAP2K6 | 0.48215383 |
| 105 | ZAP70 | 0.47574121 |
| 106 | TYK2 | 0.45360350 |
| 107 | SIK1 | 0.44487191 |
| 108 | MAPK12 | 0.43771473 |
| 109 | RIPK4 | 0.43156428 |
| 110 | PRKCI | 0.42876143 |
| 111 | AURKB | 0.42107498 |
| 112 | CSNK1E | 0.40886557 |
| 113 | SGK3 | 0.39858855 |
| 114 | CDK9 | 0.39003958 |
| 115 | MAP2K2 | 0.38972721 |
| 116 | CDK1 | 0.38234461 |
| 117 | MAPK10 | 0.37963841 |
| 118 | WEE1 | 0.37804796 |
| 119 | AURKA | 0.37190309 |
| 120 | PDK1 | 0.36975883 |
| 121 | PDGFRB | 0.36973083 |
| 122 | CAMKK1 | 0.36724980 |
| 123 | PRKD2 | 0.35720796 |
| 124 | DMPK | 0.35137263 |
| 125 | PAK6 | 0.34589588 |
| 126 | MAP3K8 | 0.34541463 |
| 127 | PAK1 | 0.34534174 |
| 128 | DYRK1B | 0.34394658 |
| 129 | ERBB2 | 0.33577116 |
| 130 | PRKAA1 | 0.33388842 |
| 131 | ILK | 0.32610436 |
| 132 | PIM2 | 0.32526491 |
| 133 | PDK2 | 0.31744697 |
| 134 | GSK3B | 0.31430027 |
| 135 | MAPKAPK3 | 0.31412497 |
| 136 | RPS6KA6 | 0.30449375 |
| 137 | PAK2 | 0.30439576 |
| 138 | ATR | 0.30216542 |
| 139 | MAPK14 | 0.29926172 |
| 140 | RAF1 | 0.29690005 |
| 141 | MAP3K2 | 0.29611745 |
| 142 | RPS6KA1 | 0.29123657 |
| 143 | MELK | 0.29108983 |
| 144 | MAPKAPK2 | 0.28797000 |
| 145 | CAMK1D | 0.28120407 |
| 146 | MAPK1 | 0.27428959 |
| 147 | STK4 | 0.26649877 |
| 148 | STK3 | 0.25774154 |
| 149 | INSR | 0.22409806 |
| 150 | ITK | 0.21836145 |
| 151 | IGF1R | 0.20356117 |
| 152 | CSNK1D | 0.19094284 |
| 153 | PAK3 | 0.18909937 |
| 154 | BUB1 | 0.18873748 |
| 155 | RPS6KA3 | 0.17708920 |
| 156 | CDK15 | 0.17130826 |
| 157 | MAPK8 | 0.16905148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 5.31123598 |
| 2 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 4.29693757 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.51855828 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 3.10699630 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.42137272 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.39288552 |
| 7 | mTOR signaling pathway_Homo sapiens_hsa04150 | 2.16795218 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.14687483 |
| 9 | Galactose metabolism_Homo sapiens_hsa00052 | 1.97077558 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.66610045 |
| 11 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.65270024 |
| 12 | Thyroid cancer_Homo sapiens_hsa05216 | 1.48303881 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 1.47343508 |
| 14 | Cell cycle_Homo sapiens_hsa04110 | 1.47229083 |
| 15 | * mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.46404852 |
| 16 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.45724913 |
| 17 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.45711818 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44602519 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.41935036 |
| 20 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.35175290 |
| 21 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33104242 |
| 22 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.32696677 |
| 23 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.32280505 |
| 24 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.31884662 |
| 25 | Prion diseases_Homo sapiens_hsa05020 | 1.29358617 |
| 26 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.28643885 |
| 27 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.27130854 |
| 28 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.25017691 |
| 29 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.24076827 |
| 30 | Mismatch repair_Homo sapiens_hsa03430 | 1.23842141 |
| 31 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.21759593 |
| 32 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.21300566 |
| 33 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.21035986 |
| 34 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.18976765 |
| 35 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.17312091 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.16633165 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11546860 |
| 38 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.11022867 |
| 39 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.06674125 |
| 40 | Prostate cancer_Homo sapiens_hsa05215 | 1.06616969 |
| 41 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.06425101 |
| 42 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.05655603 |
| 43 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.04113304 |
| 44 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.02735146 |
| 45 | Spliceosome_Homo sapiens_hsa03040 | 1.01816851 |
| 46 | Lysine degradation_Homo sapiens_hsa00310 | 1.01263220 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99262358 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99126709 |
| 49 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.99116044 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.98152490 |
| 51 | Bladder cancer_Homo sapiens_hsa05219 | 0.97916376 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 0.97364487 |
| 53 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.97246968 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.95651488 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.95607175 |
| 56 | Hepatitis B_Homo sapiens_hsa05161 | 0.95184061 |
| 57 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.95130818 |
| 58 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.94446036 |
| 59 | Base excision repair_Homo sapiens_hsa03410 | 0.89366925 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.85926471 |
| 61 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85388296 |
| 62 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.85177999 |
| 63 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.83537234 |
| 64 | Pathways in cancer_Homo sapiens_hsa05200 | 0.83319384 |
| 65 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.82581829 |
| 66 | RNA degradation_Homo sapiens_hsa03018 | 0.81114573 |
| 67 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.80407534 |
| 68 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80374860 |
| 69 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.79944598 |
| 70 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.79862255 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.79796553 |
| 72 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79499396 |
| 73 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79031027 |
| 74 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77566103 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.76457542 |
| 76 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.76119207 |
| 77 | Shigellosis_Homo sapiens_hsa05131 | 0.75592617 |
| 78 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.74920955 |
| 79 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.74459475 |
| 80 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.73795537 |
| 81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.73791462 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73603280 |
| 83 | Adherens junction_Homo sapiens_hsa04520 | 0.72962399 |
| 84 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71603283 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70377373 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.68153871 |
| 87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.67806381 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.67617368 |
| 89 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66610736 |
| 90 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66486169 |
| 91 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65666926 |
| 92 | Influenza A_Homo sapiens_hsa05164 | 0.64932167 |
| 93 | Tight junction_Homo sapiens_hsa04530 | 0.64629562 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64111330 |
| 95 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62398388 |
| 96 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62208125 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61894657 |
| 98 | Homologous recombination_Homo sapiens_hsa03440 | 0.61872979 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61675792 |
| 100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60870625 |
| 101 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59948028 |
| 102 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59533173 |
| 103 | Lysosome_Homo sapiens_hsa04142 | 0.59157618 |
| 104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.58749465 |
| 105 | Salmonella infection_Homo sapiens_hsa05132 | 0.58569586 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.58192662 |
| 107 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.58135924 |
| 108 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57168579 |
| 109 | Apoptosis_Homo sapiens_hsa04210 | 0.57103033 |
| 110 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.56997449 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56968726 |
| 112 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.56521575 |
| 113 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56259310 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55319436 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.55054086 |
| 116 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54997120 |
| 117 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.53753916 |
| 118 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52912264 |
| 119 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52715911 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52434587 |
| 121 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.51025840 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.49618200 |
| 123 | Long-term potentiation_Homo sapiens_hsa04720 | 0.49445711 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.49393484 |
| 125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.48106966 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45939254 |
| 127 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.45841273 |
| 128 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45498801 |
| 129 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.44553074 |
| 130 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.44234829 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44035083 |
| 132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43219201 |
| 133 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.42526850 |
| 134 | Focal adhesion_Homo sapiens_hsa04510 | 0.42079079 |
| 135 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40646513 |
| 136 | Glioma_Homo sapiens_hsa05214 | 0.38869254 |
| 137 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.38354226 |
| 138 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.37371079 |
| 139 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.35725706 |
| 140 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.33988623 |
| 141 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.33617600 |

